Showing results (531-540 of 602) with videos related to
Sort By:
Pageof 61
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2016
Hydrogen peroxide detoxification is a key mechanism for growth of ammonia-oxidizing archaeaJong-Geol Kim, Soo-Je Park, Jaap S Sinninghe Damsté, et al.NPJ Precision Oncology|April 6, 2024
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapySara Corvigno, Yuan Liu, Emine Bayraktar, et al.Chemical Science|September 23, 2024
Discovery of megapolipeptins by genome mining of a Burkholderiales bacteria collectionBruno S Paulo, Michael J J Recchia, Sanghoon Lee, et al.Biomaterials|April 27, 2018
Polymeric nano-shielded islets with heparin-polyethylene glycol in a non-human primate modelHyojun Park, Muhammad R Haque, Jae Berm Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA MutationTapsi Kumar, Evie Hobbs, Fei Yang, et al.Scientific Reports|June 21, 2017
Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver FailureJi-Hyun Lee, Doo-Hoon Lee, Sanghoon Lee, et al.Journal of Clinical Medicine|October 29, 2020
Outcomes of Pediatric Liver Transplantation in Korea Using Two National RegistriesSuk Kyun Hong, Nam-Joon Yi, Kyung Chul Yoon, et al.Experimental & Molecular Medicine|August 23, 2022
Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cellsSoonbum Park, Eun A Cho, Jung Nyeo Chun, et al.Journal of the National Cancer Institute|April 2, 2026
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trialDing Quan Ng, Matthew Heshmatipour, Julia Trudeau, et al.Gynecologic Oncology|October 19, 2019
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG studyShannon N Westin, Michael W Sill, Robert L Coleman, et al.Pageof 61